We are live on !
Find out more
GW & Wade Portfolio holdings
AUM
$3.08B
Turnover
13.09%
1-Year Est. Return
18.99%
This Fund
S&P 500
This Quarter Est. Return
+10.54%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$3.08B
AUM Growth
+$391M
(+15%)
Cap. Flow
+$120M
Cap. Flow % of AUM
Cap. Flow %
3.91%
Top 10 Holdings %
Top 10 Hldgs %
31.13%
Holding
443
New
32
Increased
183
Reduced
144
Closed
26
Avg Time Held
4.3
years
Top 10 Avg Time Held
4.5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$38.7M |
| 2 |
Pacer US Cash Cows 100 ETF
COWZ
|
+$13M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$12.8M |
| 4 |
Broadcom
AVGO
|
+$8.98M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$8.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$12.5M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$7.84M |
| 3 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$7.04M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$5.04M |
| 5 |
iShares Select Dividend ETF
DVY
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.06% |
| 2 | Technology | 13.97% |
| 3 | Financials | 6.24% |
| 4 | Healthcare | 6.05% |
| 5 | Consumer Staples | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Applovin
APP
$87.5B
| $2.58M | 0.08% |
64,799
| – | – |
2021 Q3
9 quarters
|
|
152
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $2.58M | 0.08% |
73,305
+6,035
| +9% | +$198K |
2021 Q2
10 quarters
|
|
153
Booking.com
BKNG
$114B
| $2.54M | 0.08% |
17,900
-2,375
| -12% | -$296K |
2020 Q4
12 quarters
|
|
154
Colgate-Palmolive
CL
$73.7B
| $2.5M | 0.08% |
31,333
-1,464
| -4% | -$110K |
2013 Q2
42 quarters
|
|
155
Keurig Dr Pepper
KDP
$47.4B
| $2.43M | 0.08% |
72,876
+28,583
| +65% | +$891K |
2019 Q3
17 quarters
|
|
156
American Tower
AMT
$87B
| $2.41M | 0.08% |
11,155
+186
| +2% | +$35.2K |
2017 Q3
25 quarters
|
|
157
Vanguard S&P 500 ETF
VOO
$1.04T
| $2.39M | 0.08% |
5,463
-18
| -0.3% | -$7.37K |
2019 Q4
16 quarters
|
|
158
Sherwin-Williams
SHW
$80.2B
| $2.37M | 0.08% |
7,602
-33
| -0.4% | -$8.87K |
2020 Q4
12 quarters
|
|
159
State Street SPDR S&P Dividend ETF
SDY
$21.9B
| $2.36M | 0.08% |
18,876
-686
| -4% | -$80.5K |
2020 Q4
12 quarters
|
|
160
iShares MSCI Emerging Markets ETF
EEM
$29B
| $2.35M | 0.08% |
58,393
-1,256
| -2% | -$48.5K |
2020 Q4
12 quarters
|
|
161
Boeing
BA
$135B
| $2.34M | 0.08% |
8,969
-197
| -2% | -$42.1K |
2015 Q1
35 quarters
|
|
162
iShares US Basic Materials ETF
IYM
$1.3B
| $2.24M | 0.07% |
16,230
-337
| -2% | -$43.3K |
2021 Q2
10 quarters
|
|
163
Adobe
ADBE
$98.1B
| $2.22M | 0.07% |
3,712
+18
| +0.5% | +$10.4K |
2020 Q1
15 quarters
|
|
164
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $2.19M | 0.07% |
43,238
+1,651
| +4% | +$80K |
2020 Q3
13 quarters
|
|
165
Berkshire Hathaway Class A
BRK.A
$1.17T
| $2.17M | 0.07% |
4
| – | – |
2014 Q4
36 quarters
|
|
166
iShares Russell Mid-Cap ETF
IWR
$57.3B
| $2.17M | 0.07% |
27,930
+1,119
| +4% | +$79.5K |
2016 Q2
30 quarters
|
|
167
BP
BP
$127B
| $2.16M | 0.07% |
61,125
-1,041
| -2% | -$38.1K |
2020 Q4
12 quarters
|
|
168
Netflix
NFLX
$262B
| $2.14M | 0.07% |
43,860
-4,550
| -9% | -$199K |
2015 Q3
33 quarters
|
|
169
Schwab U.S Small- Cap ETF
SCHA
$21.9B
| $2.13M | 0.07% |
90,042
+11,638
| +15% | +$245K |
2021 Q3
9 quarters
|
|
170
AT&T
T
$142B
| $2.13M | 0.07% |
126,738
-38,942
| -24% | -$615K |
2013 Q2
42 quarters
|
|
171
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.8B
| $2.12M | 0.07% |
4,180
+1
| +0% | +$464 |
2014 Q4
36 quarters
|
|
172
iShares Biotechnology ETF
IBB
$10.9B
| $2.11M | 0.07% |
15,515
-640
| -4% | -$78.1K |
2020 Q3
13 quarters
|
|
173
Thermo Fisher Scientific
TMO
$257B
| $2.1M | 0.07% |
3,949
-51
| -1% | -$24.7K |
2020 Q2
14 quarters
|
|
174
Novartis
NVS
$295B
| $2.06M | 0.07% |
20,428
-4
| -0% | -$386 |
2020 Q4
12 quarters
|
|
175
Regeneron Pharmaceuticals
REGN
$83.7B
| $1.96M | 0.06% |
2,229
-107
| -5% | -$88.1K |
2020 Q2
14 quarters
|
|
Similar funds
GW & Wade's Q4 2023 Portfolio in Review
As of Q4 2023, GW & Wade held 443 positions worth $3.08B, up 15% from $2.69B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
GW & Wade deployed $120M of net new capital in Q4 2023, opening 32 new positions and adding to 183 existing holdings. Its largest new stake was Fidelity Total Bond ETF: 290,986 shares worth $13.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $12.5M trimmed.
- GW & Wade's largest Q4 2023 buy was Fidelity Total Bond ETF: 290,986 shares worth $13.4M.
- GW & Wade added most to iShares 7-10 Year Treasury Bond ETF in Q4 2023, an estimated $38.7M increase.
- GW & Wade's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $12.5M.
- GW & Wade fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $7.04M.
- GW & Wade's ten largest holdings make up 31% of its $3.08B portfolio in Q4 2023.
- GW & Wade opened 32 new positions and closed 26 in Q4 2023.
- GW & Wade's portfolio value rose 15% quarter-over-quarter to $3.08B.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.